Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Enzon Pharmaceuticals Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 184.62M 50.17M 43.07M 42.6M 34.49M
Cost of Goods Sold (COGS) incl. D&A 48.28M 57.02M 41.11M - 232,000
COGS excluding D&A 29M 51.21M 35.77M - 0
Depreciation & Amortization Expense 19.28M 5.81M 5.34M 4.26M 232,000
Depreciation 8.4M 5.81M 5.34M 4.26M 232,000
Amortization of Intangibles 10.88M - - 0 0
Gross Income 136.34M (6.85M) 1.97M - 34.26M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 134.16M 27.4M 17.4M 31.22M 11.33M
Research & Development 70.23M - - 21.01M 2.72M
Other SG&A 63.94M 27.4M 17.4M 10.21M 8.61M
Other Operating Expense 0 0 0 0 0
Unusual Expense 1.61M 14.92M 1.03M 11.36M 4.78M
EBIT after Unusual Expense (1.61M) (14.92M) (1.03M) (11.36M) (4.78M)
Non Operating Income/Expense 5.01M 48.88M 91,000 912,000 1.85M
Non-Operating Interest Income 4.31M 3.47M 1.74M 1.68M 234,000
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 11.51M 6.32M 5.93M 5.27M 2.12M
Gross Interest Expense 11.51M 6.32M 5.93M 5.27M 2.12M
Interest Capitalized - - 0 0 0
Pretax Income (1.63M) (3.14M) (20.56M) (6.92M) 18.12M
Income Tax (2.31M) (337,000) 205,000 (4.14M) (28,000)
Income Tax - Current Domestic (2.09M) (337,000) 205,000 30,000 (30,000)
Income Tax - Current Foreign (223,000) 0 0 (4.17M) 2,000
Income Tax - Deferred Domestic 0 0 0 0 0
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) - 0 0 0 0
Consolidated Net Income 683,000 (2.8M) (20.76M) (2.78M) 18.15M
Minority Interest Expense 0 0 0 0 0
Net Income 683,000 (2.8M) (20.76M) (2.78M) 18.15M
Extraordinaries & Discontinued Operations 0 180.04M 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 176.42M 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 3.62M 0 0 0
Net Income After Extraordinaries 683,000 177.24M (20.76M) (2.78M) 18.15M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 683,000 (2.8M) (20.76M) (2.78M) 18.15M
EPS (Basic) 0.02 0.01 (0.40) (0.06) 0.41
Basic Shares Outstanding 45.19M 58.47M 51.91M 46.74M 43.78M
EPS (Diluted) 0.01 0.01 (0.40) (0.06) 0.36
Diluted Shares Outstanding 45.75M 58.47M 51.91M 46.74M 51.05M
EBITDA 21.46M (28.43M) (10.09M) 11.38M 23.17M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.